Healthcare Market Research Reports & Industry Analysis

Healthcare refers to the field associated with maintaining or restoring patients’ health. These days’ Healthcare Industry falls into a lashing of discrete sub-sectors, and ancillary goods and services. Ranging from therapeutic equipment to medicinal drugs, medical tourism to sickness insurance, the Healthcare Market has been one of the most swiftly expanding sectors within the globe’s economic system.

Global Healthcare spending contributes close to 10% to the whole world’s GDP, though it varies noticeably with geography. Thus, the Western world’s average healthcare costs are far greater in contrast to those in the developing economies. North America alone is in charge of circa a half of the world’s overall spending on healthcare services. With budgets curtailments and growing costs, technology advances are increasingly taking a new meaning in the global Healthcare universe.

The research reports offer comprehensive insights into the market sizing, structure and dynamics of the Healthcare Industry based on various geographies, as well as in-depth market segmentation. The research reports incorporated in this Catalogue closely investigate the competition in the Healthcare Market, besides profiling countless market participants. Moreover, tomorrow's healthcare-related challenges are addressed, as well as projections into the future are provided in the research reports.

Publications found: 71,946

Sort by:

Neuroendocrine Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Neuroendocrine Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Neuroendocrine Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and...

May 2022 173 pages

Neuroendocrine Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Neuroendocrine Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Neuroendocrine Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Typ...

May 2022 52 pages

Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) Dr...

May 2022 59 pages

Neurogenic Locus Notch Homolog Protein 1 (Translocation Associated Notch Protein TAN 1 or NOTCH1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Neurogenic Locus Notch Homolog Protein 1 (Translocation Associated Notch Protein TAN 1 or NOTCH1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players...

May 2022 38 pages

Neuroinflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Neuroinflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Neuroinflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 88 pages

Neuromuscular Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Neuromuscular Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Neuromuscular Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

May 2022 74 pages

Neuronal Acetylcholine Receptor Subunit Alpha 3 (CHRNA3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Neuronal Acetylcholine Receptor Subunit Alpha 3 (CHRNA3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Neuronal Acetylcholine Receptor...

May 2022 35 pages

Neuronal Acetylcholine Receptor Subunit Beta 4 (CHRNB4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Neuronal Acetylcholine Receptor Subunit Beta 4 (CHRNB4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Neuronal Acetylcholine Receptor S...

May 2022 36 pages

Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides a...

May 2022 85 pages

Neurotensin Receptor Type 1 (NTR1 or High Affinity Levocabastine Insensitive Neurotensin Receptor or NTRH or NTSR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Neurotensin Receptor Type 1 (NTR1 or High Affinity Levocabastine Insensitive Neurotensin Receptor or NTRH or NTSR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Ty...

May 2022 35 pages

Nicotinamide N Methyltransferase (NNMT or EC 2.1.1.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Nicotinamide N Methyltransferase (NNMT or EC 2.1.1.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Nicotinamide N Methyltransferase (N...

May 2022 38 pages

Nicotine Addiction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Nicotine Addiction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Nicotine Addiction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...

May 2022 57 pages

Niemann Pick C1 Like Protein 1 (NPC1L1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Niemann Pick C1 Like Protein 1 (NPC1L1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Niemann Pick C1 Like Protein 1 (NPC1L1) Drugs in...

May 2022 41 pages

Niemann Pick C1 Protein (NPC1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Niemann Pick C1 Protein (NPC1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Niemann Pick C1 Protein (NPC1) Drugs in Development by The...

May 2022 35 pages

Nitric Oxide Synthase (NO Synthase or NOS or EC 1.14.13.39) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Nitric Oxide Synthase (NO Synthase or NOS or EC 1.14.13.39) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Nitric Oxide Synthase (NO Syn...

May 2022 56 pages

Nodal Marginal Zone B-Cell Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Nodal Marginal Zone B-Cell Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Nodal Marginal Zone B-Cell Lymphoma Drugs in Development by Stages, Target,...

May 2022 55 pages

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Non Muscle Invasive Bladder Cancer (NMIB...

May 2022 102 pages

Non-Proliferative Diabetic Retinopathy (NPDR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Non-Proliferative Diabetic Retinopathy (NPDR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Non-Proliferative Diabetic Retinopathy (NPDR) Drugs in Development...

May 2022 40 pages

Non-Small Cell Lung Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Non-Small Cell Lung Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Non-Small Cell Lung Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Mo...

May 2022 112 pages

Nonerosive Reflux Disease (NERD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Nonerosive Reflux Disease (NERD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Nonerosive Reflux Disease (NERD) Drugs in Development by Stages, Target, MoA, R...

May 2022 36 pages

Nongerminomatous (Nonseminomatous) Germ Cell Tumors Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Nongerminomatous (Nonseminomatous) Germ Cell Tumors Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Nongerminomatous (Nonseminomatous) Germ Cell Tumors Drugs in...

May 2022 37 pages

Nonmelanomatous Skin Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Nonmelanomatous Skin Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Nonmelanomatous Skin Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecu...

May 2022 116 pages

Nonstructural Protein 1 (NS1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Nonstructural Protein 1 (NS1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Nonstructural Protein 1 (NS1) Drugs in Development by Thera...

May 2022 38 pages

Nonstructural Protein 4B (NS4B) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Nonstructural Protein 4B (NS4B) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Nonstructural Protein 4B (NS4B) Drugs in Development by T...

May 2022 35 pages

Nonstructural Protein 5A (NS5A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Nonstructural Protein 5A (NS5A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Nonstructural Protein 5A (NS5A) Drugs in Development by T...

May 2022 52 pages

Norovirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Norovirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Norovirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Ke...

May 2022 58 pages

NS5B (Nonstructural Protein 5B Polymerase or EC 2.7.7.48) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

NS5B (Nonstructural Protein 5B Polymerase or EC 2.7.7.48) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY NS5B (Nonstructural Protein 5B...

May 2022 50 pages

Nuclear Receptor Subfamily 2 Group F Member 6 (V erba Related Protein 2 or NR2F6) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Nuclear Receptor Subfamily 2 Group F Member 6 (V erba Related Protein 2 or NR2F6) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Nuclear...

May 2022 38 pages

Obstructive Sleep Apnea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Obstructive Sleep Apnea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Obstructive Sleep Apnea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

May 2022 55 pages

Ocular Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Ocular Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Ocular Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...

May 2022 164 pages

Ocular Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Ocular Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Ocular Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players...

May 2022 112 pages

Ocular Pain (Eye Pain) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Ocular Pain (Eye Pain) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Ocular Pain (Eye Pain) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type an...

May 2022 55 pages

Onchocerciasis (River Blindness) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Onchocerciasis (River Blindness) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Onchocerciasis (River Blindness) Drugs in Development by Stages, Target, MoA, R...

May 2022 40 pages

Open-Angle Glaucoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Open-Angle Glaucoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Open-Angle Glaucoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...

May 2022 81 pages

Opioid Induced Side Effects Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Opioid Induced Side Effects Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Opioid Induced Side Effects Drugs in Development by Stages, Target, MoA, RoA, Molecu...

May 2022 48 pages

Opioid Receptor (OPR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Opioid Receptor (OPR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Opioid Receptor (OPR) Drugs in Development by Therapy Areas and Ind...

May 2022 283 pages

Opium Withdrawal Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Opium Withdrawal Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Opium Withdrawal Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule T...

May 2022 39 pages

Optic Nerve Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Optic Nerve Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Optic Nerve Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...

May 2022 37 pages

Oral Cavity (Mouth) Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Oral Cavity (Mouth) Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Oral Cavity (Mouth) Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule...

May 2022 83 pages

Ornithine Carbamoyltransferase Mitochondrial (Ornithine Transcarbamylase or OTC or EC 2.1.3.3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Ornithine Carbamoyltransferase Mitochondrial (Ornithine Transcarbamylase or OTC or EC 2.1.3.3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SU...

May 2022 41 pages

Ornithine Decarboxylase (ODC or ODC1 or EC 4.1.1.17) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Ornithine Decarboxylase (ODC or ODC1 or EC 4.1.1.17) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Ornithine Decarboxylase (ODC or ODC1...

May 2022 37 pages

Oropharyngeal Candidiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Oropharyngeal Candidiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Oropharyngeal Candidiasis Drugs in Development by Stages, Target, MoA, RoA, Molecule T...

May 2022 35 pages

Osteopetrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Osteopetrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Osteopetrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players prov...

May 2022 35 pages

Otitis Externa Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Otitis Externa Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Otitis Externa Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players pr...

May 2022 37 pages

Oxysterols Receptor LXR Alpha (Liver X Receptor Alpha or Nuclear Receptor Subfamily 1 Group H Member 3 or LXRA or NR1H3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Oxysterols Receptor LXR Alpha (Liver X Receptor Alpha or Nuclear Receptor Subfamily 1 Group H Member 3 or LXRA or NR1H3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecu...

May 2022 36 pages

Oxytocin Receptor (OTR or OXTR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Oxytocin Receptor (OTR or OXTR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Oxytocin Receptor (OTR or OXTR) Drugs in Development by T...

May 2022 56 pages

P27 (Negative Regulatory Factor or Nef) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

P27 (Negative Regulatory Factor or Nef) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY P27 (Negative Regulatory Factor or Nef) Drugs in...

May 2022 41 pages

P2X Purinoceptor 7 (P2Z Receptor or P2RX7) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

P2X Purinoceptor 7 (P2Z Receptor or P2RX7) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY P2X Purinoceptor 7 (P2Z Receptor or P2RX7) Dru...

May 2022 45 pages

p38 MAP Kinase (EC 2.7.11.24) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

p38 MAP Kinase (EC 2.7.11.24) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY p38 MAP Kinase (EC 2.7.11.24) Drugs in Development by Thera...

May 2022 63 pages

Palmitoyl Protein Thioesterase 1 (Palmitoyl Protein Hydrolase 1 or CLN1 or PPT1 or EC 3.1.2.22) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Palmitoyl Protein Thioesterase 1 (Palmitoyl Protein Hydrolase 1 or CLN1 or PPT1 or EC 3.1.2.22) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players S...

May 2022 38 pages

Filters

Clear all

Price

—

Date

—

Pages

—

Offers

33% OFF on “TCR-Based Antibody a...

Discount Offer from GMD Research

280

Special Offer from MP Advisors

Special Offer on Therapy Class R...